Nausea is a recognized symptom of COVID-19, reported by roughly one in ten hospitalized patients across large studies, though rates have varied widely depending on the population studied and how the data were collected. It belongs to a cluster of gastrointestinal symptoms that can accompany or even precede the more familiar respiratory signs like cough and fever. The biology behind it turns out to be more interesting than a simple upset stomach, involving the virus’s ability to directly infect cells lining the digestive tract.
How Common Is Nausea in COVID
Prevalence figures for nausea in COVID-19 range from under 2% to as high as 30%, which is a huge spread. The variation largely comes down to study design, geographic setting, and whether researchers asked about nausea specifically or lumped it together with vomiting. One of the earliest large studies, which tracked over 1,100 hospitalized patients in Wuhan, found nausea in about 12% of cases and vomiting in about 10%.1PubMed Central. The roles of nausea and vomiting in COVID-19: did we miss something? A U.S. multicenter study of 318 hospitalized patients put the figure considerably higher, with nausea occurring in about 26% and vomiting in about 15%.1PubMed Central. The roles of nausea and vomiting in COVID-19: did we miss something?
When researchers pooled data across many studies, the numbers settled into a tighter range. A meta-analysis from the American Gastroenterological Association found the pooled rate of nausea and vomiting together to be about 8%, with a separate meta-analysis putting it at 7%.1PubMed Central. The roles of nausea and vomiting in COVID-19: did we miss something? A literature review spanning 41 studies and more than 12,000 patients, including children, found a median incidence of nausea at about 10.5%, which was nearly identical to the rate of diarrhea (about 11%) recorded in the same studies.2PubMed Central. COVID‐19, nausea, and vomiting That finding led researchers to argue that nausea deserves the same attention as diarrhea when clinicians screen for possible COVID infection.
Why COVID Targets the Gut
The virus behind COVID-19, SARS-CoV-2, enters human cells by latching onto a protein called ACE2 that sits on cell surfaces. ACE2 is abundant in the lungs, which explains the respiratory damage, but it is also heavily expressed throughout the digestive tract, from the esophagus down to the colon.3PubMed Central. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19 When the virus binds to ACE2 in the gut lining, it can damage the intestinal barrier and ramp up inflammatory signaling, which triggers nausea, vomiting, and abdominal discomfort.
The damage is not purely local. Inflammation in the gut can spill into the bloodstream and activate pathways that communicate distress to the brain’s vomiting center. The gut and brain are in constant two-way communication through what researchers call the gut-brain axis. SARS-CoV-2 appears to disrupt that communication by altering the gut’s microbial community, increasing intestinal permeability (sometimes described as “leaky gut”), and potentially impairing vagus nerve signaling.4The Annals of Internal Medicine. A Comprehensive Narrative Review on Long COVID-19 Syndrome and the Gut-Brain Axis All of these changes can produce or worsen nausea, and they help explain why some patients report gut symptoms that outlast the acute respiratory phase of the illness.
Nausea as Part of a Bigger Digestive Picture
Nausea from COVID rarely shows up in isolation. It tends to appear alongside other gastrointestinal complaints. A review of COVID’s digestive symptoms noted that the most common GI issues include loss of appetite, nausea, vomiting, diarrhea, and abdominal pain, and these frequently overlap with respiratory symptoms like fever, cough, and shortness of breath.5PubMed Central. Gastrointestinal Manifestations of COVID-19: A Review of What We Know
A study of 206 patients with mild COVID-19 split them into three groups: those with digestive symptoms only, those with both digestive and respiratory symptoms, and those with respiratory symptoms only. Nearly a quarter of the patients had digestive symptoms as their sole complaint, without the cough or sore throat that most people associate with the disease.6PubMed Central. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity That finding is worth knowing because someone experiencing mainly nausea and diarrhea might not suspect COVID at all, especially during a period when another stomach bug is circulating. The possibility of a gut-only COVID presentation means the virus can hide in plain sight if clinicians or patients focus only on respiratory clues.
Did Nausea Change Across Variants
As SARS-CoV-2 evolved through Delta, Omicron, and subsequent subvariants, the symptom profile shifted in some ways. Omicron, for instance, was associated with more sore throats and less loss of smell compared with Delta. But nausea and vomiting were among the few symptoms that did not differ between the two variants. A large contact-tracing study in England compared symptom reports across Omicron and Delta infections and found that, after adjusting for age, sex, vaccination status, and other factors, nausea and vomiting showed no meaningful difference in reporting frequency between the two variants.7PubMed Central. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England
This consistency suggests that the virus’s ability to cause nausea is tied to a stable feature of the infection, most likely the ACE2 pathway in the gut, rather than something that fluctuates with each new variant’s mutations. For you as a patient, it means nausea remains a plausible COVID symptom regardless of which strain is dominant at a given time.
When Nausea Lingers After the Acute Infection
For most people, COVID-related nausea resolves within the first week or two of illness. But a subset of patients report persistent or recurring nausea as part of long COVID. A systematic review and meta-analysis of gastrointestinal symptoms in long COVID found that the frequency of nausea and vomiting was about 6% among patients with lingering post-COVID symptoms, which was similar to the rate seen during the acute infection itself.8PubMed Central. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis
The persistence of gut symptoms months after the initial infection points to lasting disruption rather than just a temporary viral assault. Some of that disruption may involve the autonomic nervous system, which controls involuntary functions including digestion. Researchers have documented cases where long-COVID patients develop autonomic dysfunction that primarily hits the blood vessels supplying the gut. When that happens, the symptoms can look like a chronic gastrointestinal problem, with nausea, bloating, and appetite changes as dominant complaints, even without the heart-rate abnormalities seen in other forms of autonomic trouble.9Clinical and Experimental Emergency Medicine. Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome
How COVID Changes the Gut Microbiome
One reason nausea and other GI symptoms may persist after the virus itself is cleared is that COVID reshapes the bacterial community living in your gut. Across dozens of observational studies spanning populations in China, the U.S., Japan, Portugal, Germany, and elsewhere, researchers have consistently found that patients with COVID-19 show decreased bacterial diversity in their stool compared with healthy people. Specifically, beneficial bacteria from families that produce short-chain fatty acids, which help maintain a healthy gut lining, were depleted, while potentially harmful bacteria from the Enterobacteriaceae family were more abundant.10Nature Reviews Gastroenterology & Hepatology. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
These microbial shifts are not trivial. Short-chain fatty acids are a major fuel source for the cells lining the colon and play a role in regulating inflammation throughout the body. When the bacteria that produce them decline, the gut lining becomes more permeable, inflammatory molecules leak into the bloodstream more easily, and signals traveling up the gut-brain axis get noisier. For a patient, this can translate into ongoing nausea, bloating, or appetite changes that persist well beyond the acute infection. The gut-brain axis disruption driven by dysbiosis, neuroinflammation, and vagus nerve impairment has emerged as one of the leading explanations for why gastrointestinal and cognitive symptoms so often coexist in long COVID.4The Annals of Internal Medicine. A Comprehensive Narrative Review on Long COVID-19 Syndrome and the Gut-Brain Axis
The Virus in the Gut and Fecal Shedding
The fact that SARS-CoV-2 infects gut cells has a practical consequence beyond nausea: viral RNA can show up in stool. In a Korean study of 46 patients with mild or asymptomatic COVID, about 4% had detectable virus in fecal samples, and in some cases the shedding continued for up to 50 days after diagnosis.11PubMed Central. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea An Italian study found even higher rates: about 73% of patients tested positive for viral RNA in stool, and in several cases the stool samples remained positive for weeks after respiratory samples had already turned negative.12PubMed Central. Evaluation of SARS-CoV-2 viral RNA in fecal samples
The wide gap between those two numbers (4% versus 73%) reflects differences in testing frequency, patient severity, and timing of sample collection. But the consistent takeaway is that the virus does replicate in the gastrointestinal tract, and the gut is not merely an innocent bystander catching spillover from the lungs. This active gut involvement is the biological foundation for COVID-related nausea and other digestive symptoms. It also means that wastewater surveillance, which detects viral fragments in sewage, can serve as an early warning system for COVID surges in a community, precisely because the virus persists in the gut and gets excreted long after a person feels better.
Managing Nausea During COVID
There is no COVID-specific anti-nausea drug, and in most cases the nausea resolves on its own as the body clears the infection. Standard supportive care applies: small, frequent meals; bland foods; staying upright after eating; and avoiding strong smells that might trigger waves of queasiness. Oral hydration is particularly important because nausea often leads to reduced fluid intake, and dehydration can compound the problem. Some clinicians have highlighted oral hydration therapy as an underappreciated tool for preventing the escalation of nausea and vomiting in COVID patients, reducing the need for intravenous fluids.13PubMed Central. Oral hydration therapy is an alternative approach to prevent nausea and vomiting in patients with COVID-19
Over-the-counter anti-nausea medications like ondansetron or dimenhydrinate are options worth discussing with a doctor if the nausea is interfering with your ability to eat or drink. It is also worth keeping in mind that some medications used to treat COVID itself can cause or worsen nausea as a side effect. If you are taking antivirals or other prescribed treatments and your nausea suddenly gets worse, mention it to your provider rather than assuming it is all from the virus.
When to Take Gut Symptoms Seriously
Most COVID-related nausea is uncomfortable but manageable. There are situations, though, where it warrants more attention. If nausea is accompanied by an inability to keep fluids down for more than a day, severe abdominal pain, bloody stool, or signs of dehydration like dark urine and dizziness, those are reasons to seek medical care regardless of whether you have tested positive for COVID. In rare cases, COVID can trigger inflammation of the pancreas or liver, and persistent vomiting with upper abdominal pain could signal one of these complications.
For people with pre-existing gastrointestinal conditions such as irritable bowel syndrome, inflammatory bowel disease, or gastroparesis, a COVID infection may temporarily flare those conditions. The inflammatory surge and microbiome disruption associated with COVID can amplify symptoms you already manage on a regular basis. If your baseline gut symptoms worsen noticeably during or after COVID, that is worth discussing with a gastroenterologist rather than waiting it out indefinitely.
Nausea Without a Positive Test
A common practical question is whether new-onset nausea should prompt a COVID test. The answer depends on context. If you have nausea with no fever, no cough, and no known exposure, the odds favor a more common cause like food intolerance, stress, or a norovirus-type stomach bug. But if your nausea coincides with other COVID-associated symptoms, even mild ones like fatigue, headache, or a scratchy throat, or if there is a known outbreak in your household or workplace, testing makes sense. The fact that nearly a quarter of mild COVID cases in one study presented with digestive symptoms alone means gut-only presentations are not rare enough to ignore.6PubMed Central. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity
Rapid antigen tests are less sensitive during the first day or two of symptoms, so a negative result on the day your nausea starts does not rule out COVID entirely. If your symptoms persist or new ones develop, retesting 48 hours later improves accuracy. The era of widespread testing has wound down in many places, but for people at high risk of severe outcomes, or those who live with someone who is, a test remains a useful tool for deciding whether to start antiviral treatment early.
How Nausea Compares With Other COVID Gut Symptoms
Among the GI symptoms associated with COVID, diarrhea has received the most attention, partly because it is easier to measure and partly because early reports from China emphasized it. But the data suggest nausea is about equally common. Across the 41-study analysis mentioned earlier, the median rate of nausea (10.5%) was nearly the same as diarrhea (11%), while vomiting (about 7%) came in at a rate similar to abdominal pain (about 7%).2PubMed Central. COVID‐19, nausea, and vomiting Loss of appetite has sometimes been reported at even higher rates, though it is harder to separate from the general malaise that accompanies any viral illness.
The practical point is that nausea is not a fringe symptom or a footnote in the COVID symptom list. It sits squarely in the middle of the gastrointestinal cluster, roughly as common as diarrhea and more common than abdominal pain. If you have experienced a stomach flu that turned out to be COVID, you are not an outlier. You are part of a pattern that took the medical community a couple of years to fully appreciate.